According to Hims & Hers Health's latest financial reports the company has a price-to-book ratio of 12.2.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | N/A | -100% |
2023-12-31 | 5.48 | 28.39% |
2022-12-31 | 4.27 | 7.02% |
2021-12-31 | 3.99 | |
2020-12-31 | N/A | |
2019-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Organovo ONVO | 2.05 | -83.17% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | 4.74 | -61.21% | ๐ฌ๐ง UK |
Novavax NVAX | -2.59 | -121.22% | ๐บ๐ธ USA |
Novocure
NVCR | 6.67 | -45.37% | Jersey |